{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:50:22Z","timestamp":1792036222425,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["200170F"],"award-info":[{"award-number":["200170F"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2017\/704"],"award-info":[{"award-number":["CAN 2017\/704"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2020-01963"],"award-info":[{"award-number":["2020-01963"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["FoUI-953912"],"award-info":[{"award-number":["FoUI-953912"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["Dnr 2019-00446"],"award-info":[{"award-number":["Dnr 2019-00446"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","award":["201313"],"award-info":[{"award-number":["201313"]}],"id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.eclinm.2023.102335","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T18:38:11Z","timestamp":1701974291000},"page":"102335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths \u2013 a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-6181","authenticated-orcid":false,"given":"Kenny A.","family":"Rodriguez-Wallberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Kieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Foukakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sara","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-7178","authenticated-orcid":false,"given":"Frida E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eclinm.2023.102335_bib1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood.V58.4.849.849","article-title":"Protection of ovarian function by oral contraceptives in women receiving chemotherapy for hodgkin's disease","volume":"58","author":"Chapman","year":"1981","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102335_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","article-title":"Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019","volume":"30","author":"Burstein","year":"2019","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102335_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Paluch-Shimon","year":"2022","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102335_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2020.08.011","article-title":"Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons","volume":"114","author":"Dolmans","year":"2020","journal-title":"Fertil Steril"},{"issue":"22","key":"10.1016\/j.eclinm.2023.102335_bib5","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.eclinm.2023.102335_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient\u2013level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102335_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102335_bib8","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102335_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/AOG.0000000000000905","article-title":"Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis","volume":"126","author":"Elgindy","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.eclinm.2023.102335_bib10","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102335_bib11","article-title":"ESHRE guideline group on female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.eclinm.2023.102335_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bpobgyn.2019.10.008","article-title":"Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus","volume":"64","author":"Kado","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102335_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.fertnstert.2006.10.004","article-title":"Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy","volume":"87","author":"Castelo-Branco","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eclinm.2023.102335_bib14","series-title":"The Swedish Medical Birth Register\u2014a summary of content and quality","author":"K\u00e4ll\u00e9n","year":"2003"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102335_bib15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/humrep\/deaa029","article-title":"Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study","volume":"35","author":"Marklund","year":"2020","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102335_bib16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/aogs.12934","article-title":"Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries\u2014compilation of 20 years of multicenter experience","volume":"95","author":"Rodriguez-Wallberg","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102335_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/aogs.13559","article-title":"A\u00a0prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden\u2014trends in patients' choices and benefit of the chosen methods after long-term follow-up","volume":"98","author":"Rodriguez-Wallberg","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.eclinm.2023.102335_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/aogs.13588","article-title":"National guidelines and multilingual age-adapted patient brochures and videos as decision aids for fertility preservation (FP) of children and teenagers with cancer-A multidisciplinary effort to improve children's information and access to FP in Sweden","volume":"98","author":"Rodriguez-Wallberg","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"23","key":"10.1016\/j.eclinm.2023.102335_bib19","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc1504241","article-title":"Ovarian protection during adjuvant chemotherapy","volume":"372","author":"Oktay","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102335_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1200\/JCO.18.00420","article-title":"Utility of gonadotropin-releasing hormone agonists for fertility preservation: lack of biologic basis and the need to prioritize proven methods","volume":"37","author":"Turan","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102335_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/annonc\/mdv554","article-title":"Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?","volume":"27","author":"Rodriguez-Wallberg","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eclinm.2023.102335_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/CLEP.S314959","article-title":"Nordic health registry-based research: a review of health care systems and key registries","volume":"13","author":"Laugesen","year":"2021","journal-title":"Clin Epidemiol"},{"issue":"6408","key":"10.1016\/j.eclinm.2023.102335_bib23","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.361.6408.1184","article-title":"The metawars","volume":"361","author":"De Vrieze","year":"2018","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102335_bib24","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/humrep\/dew120","article-title":"A\u00a0randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer","volume":"31","author":"Groenewoud","year":"2016","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102335_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa1808737","article-title":"A\u00a0randomized trial of endometrial scratching before in\u00a0vitro fertilization","volume":"380","author":"Lensen","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102335_bib26","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1200\/JCO.2012.42.8185","article-title":"Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial","volume":"31","author":"Demeestere","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102335_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","article-title":"Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial","volume":"121","author":"Elgindy","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"18","key":"10.1016\/j.eclinm.2023.102335_bib28","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"International breast cancer study group; POSITIVE trial collaborators. interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102335_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/dey321","article-title":"Elective and Onco-fertility preservation: factors related to IVF outcomes","volume":"33","author":"Cobo","year":"2018","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102335_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.fertnstert.2017.10.029","article-title":"Long-term outcomes in cancer patients who did or did not pursue fertility preservation","volume":"109","author":"Moravek","year":"2018","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102335_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jamaoncol.2020.5957","article-title":"Reproductive outcomes after breast cancer in women with vs without fertility preservation","volume":"7","author":"Marklund","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023005126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:25:09Z","timestamp":1762899909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023005126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"alternative-id":["S2589537023005126"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102335","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths \u2013 a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102335"}}